Alpha 2.0
Login Register
» Authors » Keith Baleeta

Keith Baleeta

Explore the profile of Keith Baleeta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 48
Followers 0
Related Specialties
Public Health
Infectious Diseases
Health Services
Top 10 Co-Authors
Augustin Muhwezi
Diana M Gibb
Laura McGough
Shepherd Mudzingwa
Jane Mallewa
Andrew J Prendergast
Mutsa Bwakura-Dangarembizi
Margaret J Thomason
Nathan Tumwesigye
Anthony Etyang
Published In
Clin Infect Dis
Glob Health Sci Pract
Lancet HIV
BMJ Glob Health
BMC Health Serv Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term retention and positive deviant practices in Uganda's community client-led antiretroviral distribution groups (CCLADs): a mixed-methods study
Natukunda J, Baleeta K, Kiriya J, Ong K, Carandang R, Muhwezi A, et al.
BMJ Glob Health . 2024 Aug; 9(8). PMID: 39134343
Background: HIV testing and starting antiretroviral therapy (ART) are pivotal in treating people living with HIV (PLHIV) but sustaining PLHIV on treatment remains challenging. We assessed retention and attrition in...
2.
Improving Iron and Folic Acid Supplementation Among Pregnant Women: An Implementation Science Approach in East-Central Uganda
Luwangula A, McGough L, Tetui M, Wamani H, Ssennono M, Agabiirwe C, et al.
Glob Health Sci Pract . 2023 Mar; 10(6). PMID: 36951283
Introduction: To address maternal iron-deficiency anemia and low uptake of iron and folic acid supplementation (IFAS) among antenatal care (ANC) clinic attendees in East-Central Uganda, the Anemia Implementation Science Initiative...
3.
Factors that influence the satisfaction of people living with HIV with differentiated antiretroviral therapy delivery models in east Central Uganda: a cross-sectional study
Baleeta K, Muhwezi A, Tumwesigye N, Kintu B, Riese S, Byonanebye D, et al.
BMC Health Serv Res . 2023 Feb; 23(1):127. PMID: 36750840
Background: The World Health Organization (WHO) and the Uganda Ministry of Health recommend differentiated service delivery models (DSDMs) as patient-centered antiretroviral therapy (ART) mechanisms for people living with HIV/AIDS (PLHIV)...
4.
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
Mallewa J, Szubert A, Mugyenyi P, Chidziva E, Thomason M, Chepkorir P, et al.
Lancet HIV . 2018 Apr; 5(5):e231-e240. PMID: 29653915
Background: In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have a high risk of mortality during the first few months after starting antiretroviral therapy (ART). We hypothesise that universally providing ready-to-use...
5.
Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
Siika A, McCabe L, Bwakura-Dangarembizi M, Kityo C, Mallewa J, Berkley J, et al.
Clin Infect Dis . 2018 Mar; 66(suppl_2):S140-S146. PMID: 29514235
Background: Severely immunocompromised human immunodeficiency virus (HIV)-infected individuals have high mortality shortly after starting antiretroviral therapy (ART). We investigated predictors of early mortality and "late presenter" phenotypes. Methods: The Reduction...